🔥 Wednesday 30 April 2025 Wed, 30 Apr 2025

Sunstone Metals Limited reports maiden resource estimates and exploration targets for its Ecuador copper-gold projects, while progressing multiple corporate partnership discussions to unlock value.

American West Metals has unveiled a positive Preliminary Economic Analysis for its Storm Copper Project in Canada, outlining a low-cost, 10-year production plan with strong financial returns. The company also secured a strategic funding and offtake partnership with Ocean Partners, while advancing its critical minerals projects in the US.

EV Resources Limited advances its position in the critical antimony market with a 70% stake acquisition in Mexico’s Los Lirios project and full ownership of Utah’s historic Coyote Creek claims, setting the stage for exploration and development.

Blue Star Helium has reported strong flow test results from its Bubba State 3 well in Lincoln County, Colorado, confirming helium concentrations around 2.01% and robust production rates that support further development.

RLF AgTech has secured major national distribution agreements in Australia, launched a comprehensive retail rollout, and restructured its manufacturing arm, LiquaForce, to drive growth and operational efficiency. The company also reported strong financial performance and expanded its footprint across Asia.

Toubani Resources has raised A$29 million through a strategic placement led by A2MP Investments, which also commits to a US$160 million debt facility, positioning the Kobada Gold Project for a final investment decision by late 2025.

Medallion Metals has advanced negotiations to acquire the Cosmic Boy Process Plant at Forrestania, while delivering robust drilling results at Ravensthorpe and securing a $6.5 million placement to fund its sulphide development strategy.

Alterity Therapeutics reports compelling Phase 2 clinical trial results for ATH434 in Multiple System Atrophy, alongside a significant capital raise strengthening its financial position for upcoming regulatory milestones.

Adriatic Metals delivered a strong Q1 2025 with a 46% jump in silver equivalent production and a 26% rise in sales, setting the stage for commercial production in Q2. Key infrastructure milestones and debt repayments underpin confidence in the company’s growth trajectory.

Adherium Limited reports a surge in US commercial patients for its Hailie Smartinhaler platform, alongside strategic hires and a new product launch compatible with AstraZeneca inhalers, underpinning plans for a capital raise.

Kingsrose Mining advances its Fennoscandian exploration with high-grade discoveries and strategic acquisition of the Jakon project, supported by robust funding from BHP.

Impact Minerals reports significant progress across multiple fronts, including a major nickel-copper-PGM anomaly at Arkun and nearing completion of the Lake Hope High Purity Alumina pre-feasibility study.

CZR Resources has terminated its prior deal with Miracle Iron and endorsed a superior A$75 million cash offer from the Rio Tinto-led Robe River Iron Associates JV for its Robe Mesa Project. The company retains promising gold and titanium-vanadium assets while preparing for shareholder approval.

Beonic Limited reported a 6.5% increase in annual recurring revenue to $17.8 million and a significant gross margin improvement to 75.5%, driven by new global contracts and disciplined cost management. The company targets cash flow breakeven in Q4 FY25 and an EBITDA margin of up to 15%.

Axel REE Limited advances its flagship Caladão REE-Gallium Project with significant high-grade intercepts and begins a maiden Mineral Resource Estimate, backed by $9.6 million in cash and strategic government partnerships.

Terra Metals has made significant strides at its Dante polymetallic project, producing three high-grade concentrates and extending mineralisation, while securing a strategic tenement option to expand its resource base.

Microba Life Sciences reported robust Q3 FY25 growth in its microbiome diagnostic tests, led by MetaXplore and MetaPanel, while advancing its therapeutics pipeline and projecting strong full-year revenue growth.

GBM Resources reports promising gold anomalism from Newmont’s initial 5,499m air core drilling at the Mt Coolon Project, advancing a key farm-in milestone and setting the stage for expanded exploration in 2025.

Petratherm Limited has confirmed a significant titanium-rich heavy mineral sands discovery at its Muckanippie Project, with drilling extending mineralisation over 15 square kilometres and a recent $8.1 million placement to accelerate development.

Microba Life Sciences reports robust growth in microbiome diagnostic testing across Australia and the UK, while advancing US market entry plans and transitioning its Therapeutics business to a partnering model.

Trigg Minerals has solidified its ownership of the Wild Cattle Creek antimony deposit with NSW government approval and confirmed high-grade antimony and tungsten mineralisation beneath the site. The company also expanded its New South Wales footprint through strategic acquisitions of historic gold and antimony projects.

Narryer Metals reports compelling scandium, gallium, and rare earth assay results at its Rocky Gully Project, alongside advancing a titanium-rich heavy mineral sands discovery through its JV with Petratherm at Muckanippie.

Nagambie Resources reported significant new antimony-gold intersections at its Nagambie Mine and joined a US Department of Defence consortium, positioning itself amid soaring antimony prices and strategic demand. The company also advanced funding arrangements and plans a resource update in the June quarter.

INOVIQ Limited reports significant progress in its exosome-based cancer diagnostics and therapeutics, including expanded customer adoption, advanced AI screening tests, and strategic partnerships with leading research centres.